Abstract: A method is provided for reducing side effects while treating a mammal using indole-3-carbinol, which method includes the steps of administering an effective amount of indole-3-carbinol along with side effect-reducing amounts of a side-effect reducing component. A composition is also provided, as are various combinations of side effect-reducing agents.

Abstract: A particulate sweetener composition includes a terpene glycoside component; a sugar alcohol component; and a terpene glycoside carrier component, wherein the composition is non-hydroscopic. The preferred carrier is fructose. A method is also provided for making the composition.

Abstract: An herbal sweetener composition includes a naturally occurring sugar selected from the group consisting of glucose, fructose, maltose and mixtures thereof and a terpene glycoside. The composition is ideal for individuals concerned about elevated blood sugar levels and the like, and a method is also provided.

Abstract: A caffeine replacement composition including a first plant extract portion containing at least one flavoglycoside selected from the group consisting of quercetin, quercetagetin, ginkgetin, biloba, isorhamnetin, kaempferol, rutin, isoginkgetin, ginnol, and mixtures thereof; a second plant extract portion containing Ginkgolactones; and a third plant extract portion containing a component selected from the group consisting of puerarin, acetylpuerarin, puerarin-xyloside and combinations thereof. These extracts are preferably obtained from Ginkgo biloba and kudzu (Pueraria).

Abstract: A composition for inhibiting oral bacteria, including a polyphenol derivative composition; and at least one composition selected from the group consisting of mogroside derivative composition, licorice extract and combinations thereof, wherein the composition is effective to inhibit growth of oral microbials.

Abstract: A process is provided for obtaining diterpene glycosides which process extracts such diterpene glycosides from plant or botanical material so as to provide a product which is high in content of such diterpene glycosides, and substantially free of bitter tasting tannins. This advantageously provides a product which can be used as a sweetener material.

Abstract: An herbal treatment composition is provided which includes Sarcandra glabra and a polysaccharide preferably derived from certain medicinal mushrooms. Methods for treating psoriasis and purpura using the composition are also disclosed.

Abstract: The process includes obtaining a liquid extract from a fresh plant source material and mixing the extract with a solution saturated with at least one element having an oxidation number of one or two or combinations thereof. The resulting mixture provides for a solid precipitate material and a liquid portion containing the triterpene glycosides of which is then passed through a macroporous resin. The resin is then washed with an alcohol to obtain a solution thereof containing the triterpene glycosides. The solution is condensed to provide a purified liquid triterpene glycoside solution and then a drying step is performed to obtain a dry composition containing the triterpene glycosides.

Abstract: An herbal sweetening, preservative and therapeutic composition includes triterpene glycoside composition and extract of licorice, wherein the composition has sweetening and anti-microbial properties, wherein the triterpene glycoside composition is standardized for 80% (wt.) of mogrosides obtained from a plant selected from the group consisting of the members of Cucurbitaceae family, Momordica family and combination thereof, and wherein the extract of licorice is the ethanol soluble and water insoluble fraction. Products including such compositions are also disclosed.

Abstract: An herbal treatment composition is provided which includes Sarcandra glabra and a polysaccharide derived from medicinal mushrooms. Methods for treating psoriasis and purpura using the composition are also disclosed.

Abstract: An herbal treatment composition includes a combination of mushroom derived polysaccharides wherein the polysaccharides are derived from at least two mushrooms from the group consisting of Maitake, Shiitake, Reishi, Poria, Cordyceps and Hericium.

Abstract: Oligonucleotides having approximately 8 to 18 nucleotide units and a 3'-tail which includes asteroid structure attached to the 3'-end through the A ring of the steroid skeleton and which form substantially stable duplexes at physiological temperature, have selective cytotoxic activity against certain tumor cell lines.